nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—SCN10A—skin cancer	0.568	1	CbGaD
Bupivacaine—CYP1A2—Imiquimod—skin cancer	0.0631	0.192	CbGbCtD
Bupivacaine—CYP2C19—Vismodegib—skin cancer	0.0474	0.144	CbGbCtD
Bupivacaine—CYP1A2—Vemurafenib—skin cancer	0.0346	0.105	CbGbCtD
Bupivacaine—CYP3A4—Imiquimod—skin cancer	0.0331	0.1	CbGbCtD
Bupivacaine—CYP3A4—Temozolomide—skin cancer	0.0331	0.1	CbGbCtD
Bupivacaine—CYP2D6—Vemurafenib—skin cancer	0.0285	0.0866	CbGbCtD
Bupivacaine—CYP1A2—Dacarbazine—skin cancer	0.0265	0.0806	CbGbCtD
Bupivacaine—CYP3A4—Vismodegib—skin cancer	0.0229	0.0697	CbGbCtD
Bupivacaine—CYP3A4—Vemurafenib—skin cancer	0.0181	0.0551	CbGbCtD
Bupivacaine—CYP1A2—Fluorouracil—skin cancer	0.0155	0.0472	CbGbCtD
Bupivacaine—CYP3A4—Docetaxel—skin cancer	0.00621	0.0189	CbGbCtD
Bupivacaine—Levobupivacaine—SCN10A—skin cancer	0.00149	0.283	CrCbGaD
Bupivacaine—Mepivacaine—SCN10A—skin cancer	0.00122	0.231	CrCbGaD
Bupivacaine—Ropivacaine—SCN10A—skin cancer	0.000961	0.182	CrCbGaD
Bupivacaine—Tocainide—SCN10A—skin cancer	0.000904	0.171	CrCbGaD
Bupivacaine—Lidocaine—SCN10A—skin cancer	0.000698	0.133	CrCbGaD
Bupivacaine—PTGER1—Prostanoid ligand receptors—PTGER4—skin cancer	0.000447	0.168	CbGpPWpGaD
Bupivacaine—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.000346	0.13	CbGpPWpGaD
Bupivacaine—PTGER1—Eicosanoid ligand-binding receptors—PTGER4—skin cancer	0.000297	0.112	CbGpPWpGaD
Bupivacaine—Cardiac arrest—Fluorouracil—skin cancer	0.000252	0.00264	CcSEcCtD
Bupivacaine—Haematuria—Bleomycin—skin cancer	0.000251	0.00263	CcSEcCtD
Bupivacaine—Convulsion—Imiquimod—skin cancer	0.000251	0.00263	CcSEcCtD
Bupivacaine—Abdominal distension—Temozolomide—skin cancer	0.000251	0.00263	CcSEcCtD
Bupivacaine—Hypertension—Imiquimod—skin cancer	0.00025	0.00262	CcSEcCtD
Bupivacaine—Dysphagia—Temozolomide—skin cancer	0.000249	0.00261	CcSEcCtD
Bupivacaine—Neuropathy—Docetaxel—skin cancer	0.000248	0.0026	CcSEcCtD
Bupivacaine—Arthralgia—Imiquimod—skin cancer	0.000246	0.00258	CcSEcCtD
Bupivacaine—Anxiety—Imiquimod—skin cancer	0.000246	0.00257	CcSEcCtD
Bupivacaine—PTGER1—Small Ligand GPCRs—PTGER4—skin cancer	0.000246	0.0923	CbGpPWpGaD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000245	0.00256	CcSEcCtD
Bupivacaine—Sweating increased—Temozolomide—skin cancer	0.000243	0.00254	CcSEcCtD
Bupivacaine—Decreased appetite—Vemurafenib—skin cancer	0.000241	0.00252	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000239	0.00251	CcSEcCtD
Bupivacaine—Constipation—Vemurafenib—skin cancer	0.000237	0.00248	CcSEcCtD
Bupivacaine—Oedema—Imiquimod—skin cancer	0.000236	0.00248	CcSEcCtD
Bupivacaine—Lightheadedness—Docetaxel—skin cancer	0.000236	0.00247	CcSEcCtD
Bupivacaine—Hypoaesthesia—Bleomycin—skin cancer	0.000235	0.00246	CcSEcCtD
Bupivacaine—Pulmonary oedema—Docetaxel—skin cancer	0.000235	0.00246	CcSEcCtD
Bupivacaine—Infection—Imiquimod—skin cancer	0.000235	0.00246	CcSEcCtD
Bupivacaine—Muscular weakness—Fluorouracil—skin cancer	0.000234	0.00245	CcSEcCtD
Bupivacaine—Shock—Imiquimod—skin cancer	0.000232	0.00244	CcSEcCtD
Bupivacaine—Nervous system disorder—Imiquimod—skin cancer	0.000232	0.00243	CcSEcCtD
Bupivacaine—Tachycardia—Imiquimod—skin cancer	0.000231	0.00242	CcSEcCtD
Bupivacaine—Skin disorder—Imiquimod—skin cancer	0.00023	0.0024	CcSEcCtD
Bupivacaine—Dysphagia—Fluorouracil—skin cancer	0.000229	0.0024	CcSEcCtD
Bupivacaine—Hyperhidrosis—Imiquimod—skin cancer	0.000228	0.00239	CcSEcCtD
Bupivacaine—Infestation—Temozolomide—skin cancer	0.000222	0.00233	CcSEcCtD
Bupivacaine—Infestation NOS—Temozolomide—skin cancer	0.000222	0.00233	CcSEcCtD
Bupivacaine—Flushing—Bleomycin—skin cancer	0.000219	0.0023	CcSEcCtD
Bupivacaine—Body temperature increased—Vemurafenib—skin cancer	0.000219	0.00229	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Temozolomide—skin cancer	0.000218	0.00228	CcSEcCtD
Bupivacaine—Urinary tract infection—Temozolomide—skin cancer	0.000216	0.00226	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000215	0.00226	CcSEcCtD
Bupivacaine—Insomnia—Imiquimod—skin cancer	0.000214	0.00224	CcSEcCtD
Bupivacaine—Paraesthesia—Imiquimod—skin cancer	0.000212	0.00222	CcSEcCtD
Bupivacaine—Chills—Bleomycin—skin cancer	0.000212	0.00222	CcSEcCtD
Bupivacaine—Dyspnoea—Imiquimod—skin cancer	0.000211	0.00221	CcSEcCtD
Bupivacaine—Somnolence—Imiquimod—skin cancer	0.00021	0.0022	CcSEcCtD
Bupivacaine—Dyspepsia—Imiquimod—skin cancer	0.000208	0.00218	CcSEcCtD
Bupivacaine—Erythema—Bleomycin—skin cancer	0.000206	0.00215	CcSEcCtD
Bupivacaine—Decreased appetite—Imiquimod—skin cancer	0.000205	0.00215	CcSEcCtD
Bupivacaine—Infestation—Fluorouracil—skin cancer	0.000205	0.00214	CcSEcCtD
Bupivacaine—Infestation NOS—Fluorouracil—skin cancer	0.000205	0.00214	CcSEcCtD
Bupivacaine—Flushing—Dactinomycin—skin cancer	0.000205	0.00214	CcSEcCtD
Bupivacaine—Hypersensitivity—Vemurafenib—skin cancer	0.000204	0.00214	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000204	0.00214	CcSEcCtD
Bupivacaine—Pain—Imiquimod—skin cancer	0.000202	0.00212	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000201	0.0021	CcSEcCtD
Bupivacaine—Urinary tract infection—Fluorouracil—skin cancer	0.000199	0.00208	CcSEcCtD
Bupivacaine—Asthenia—Vemurafenib—skin cancer	0.000199	0.00208	CcSEcCtD
Bupivacaine—Hypoaesthesia—Temozolomide—skin cancer	0.000198	0.00208	CcSEcCtD
Bupivacaine—Chills—Dactinomycin—skin cancer	0.000198	0.00207	CcSEcCtD
Bupivacaine—Oedema peripheral—Temozolomide—skin cancer	0.000196	0.00206	CcSEcCtD
Bupivacaine—Pruritus—Vemurafenib—skin cancer	0.000196	0.00205	CcSEcCtD
Bupivacaine—Lethargy—Docetaxel—skin cancer	0.000196	0.00205	CcSEcCtD
Bupivacaine—Feeling abnormal—Imiquimod—skin cancer	0.000195	0.00204	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Imiquimod—skin cancer	0.000193	0.00202	CcSEcCtD
Bupivacaine—Erythema—Dactinomycin—skin cancer	0.000192	0.00201	CcSEcCtD
Bupivacaine—Anaemia—Bleomycin—skin cancer	0.00019	0.00199	CcSEcCtD
Bupivacaine—Diarrhoea—Vemurafenib—skin cancer	0.00019	0.00199	CcSEcCtD
Bupivacaine—Urticaria—Imiquimod—skin cancer	0.000188	0.00197	CcSEcCtD
Bupivacaine—Abdominal pain—Imiquimod—skin cancer	0.000187	0.00196	CcSEcCtD
Bupivacaine—Body temperature increased—Imiquimod—skin cancer	0.000187	0.00196	CcSEcCtD
Bupivacaine—Tinnitus—Temozolomide—skin cancer	0.000186	0.00195	CcSEcCtD
Bupivacaine—Flushing—Temozolomide—skin cancer	0.000185	0.00194	CcSEcCtD
Bupivacaine—Cardiac disorder—Temozolomide—skin cancer	0.000185	0.00194	CcSEcCtD
Bupivacaine—Dizziness—Vemurafenib—skin cancer	0.000183	0.00192	CcSEcCtD
Bupivacaine—Hypoaesthesia—Fluorouracil—skin cancer	0.000183	0.00191	CcSEcCtD
Bupivacaine—Cough—Bleomycin—skin cancer	0.000179	0.00188	CcSEcCtD
Bupivacaine—Chills—Temozolomide—skin cancer	0.000179	0.00187	CcSEcCtD
Bupivacaine—Anaemia—Dactinomycin—skin cancer	0.000177	0.00186	CcSEcCtD
Bupivacaine—Vomiting—Vemurafenib—skin cancer	0.000176	0.00185	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Docetaxel—skin cancer	0.000175	0.00183	CcSEcCtD
Bupivacaine—Mental disorder—Temozolomide—skin cancer	0.000175	0.00183	CcSEcCtD
Bupivacaine—Hypersensitivity—Imiquimod—skin cancer	0.000174	0.00182	CcSEcCtD
Bupivacaine—Headache—Vemurafenib—skin cancer	0.000174	0.00182	CcSEcCtD
Bupivacaine—Malnutrition—Temozolomide—skin cancer	0.000174	0.00182	CcSEcCtD
Bupivacaine—Erythema—Temozolomide—skin cancer	0.000174	0.00182	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000173	0.00181	CcSEcCtD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.00017	0.0641	CbGpPWpGaD
Bupivacaine—Asthenia—Imiquimod—skin cancer	0.00017	0.00178	CcSEcCtD
Bupivacaine—Confusional state—Bleomycin—skin cancer	0.000169	0.00177	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000169	0.00177	CcSEcCtD
Bupivacaine—Anaphylactic shock—Bleomycin—skin cancer	0.000168	0.00176	CcSEcCtD
Bupivacaine—Oedema—Bleomycin—skin cancer	0.000168	0.00176	CcSEcCtD
Bupivacaine—Back pain—Temozolomide—skin cancer	0.000168	0.00176	CcSEcCtD
Bupivacaine—Pruritus—Imiquimod—skin cancer	0.000167	0.00175	CcSEcCtD
Bupivacaine—Infection—Bleomycin—skin cancer	0.000167	0.00175	CcSEcCtD
Bupivacaine—Dysphagia—Docetaxel—skin cancer	0.000166	0.00173	CcSEcCtD
Bupivacaine—Nausea—Vemurafenib—skin cancer	0.000165	0.00172	CcSEcCtD
Bupivacaine—Arrhythmia—Fluorouracil—skin cancer	0.000164	0.00172	CcSEcCtD
Bupivacaine—Vision blurred—Temozolomide—skin cancer	0.000164	0.00171	CcSEcCtD
Bupivacaine—Bronchospasm—Docetaxel—skin cancer	0.000163	0.00171	CcSEcCtD
Bupivacaine—Tremor—Temozolomide—skin cancer	0.000163	0.0017	CcSEcCtD
Bupivacaine—Diarrhoea—Imiquimod—skin cancer	0.000162	0.00169	CcSEcCtD
Bupivacaine—Anaemia—Temozolomide—skin cancer	0.00016	0.00168	CcSEcCtD
Bupivacaine—Erythema—Fluorouracil—skin cancer	0.00016	0.00167	CcSEcCtD
Bupivacaine—Agitation—Temozolomide—skin cancer	0.000159	0.00167	CcSEcCtD
Bupivacaine—Angioedema—Temozolomide—skin cancer	0.000159	0.00166	CcSEcCtD
Bupivacaine—Hypotension—Bleomycin—skin cancer	0.000157	0.00164	CcSEcCtD
Bupivacaine—Oedema—Dactinomycin—skin cancer	0.000157	0.00164	CcSEcCtD
Bupivacaine—Dizziness—Imiquimod—skin cancer	0.000156	0.00164	CcSEcCtD
Bupivacaine—Infection—Dactinomycin—skin cancer	0.000156	0.00163	CcSEcCtD
Bupivacaine—Palpitations—Temozolomide—skin cancer	0.000153	0.00161	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000153	0.0016	CcSEcCtD
Bupivacaine—Cough—Temozolomide—skin cancer	0.000151	0.00159	CcSEcCtD
Bupivacaine—Paraesthesia—Bleomycin—skin cancer	0.000151	0.00158	CcSEcCtD
Bupivacaine—Vision blurred—Fluorouracil—skin cancer	0.000151	0.00158	CcSEcCtD
Bupivacaine—Convulsion—Temozolomide—skin cancer	0.00015	0.00157	CcSEcCtD
Bupivacaine—Vomiting—Imiquimod—skin cancer	0.00015	0.00157	CcSEcCtD
Bupivacaine—Hypertension—Temozolomide—skin cancer	0.00015	0.00157	CcSEcCtD
Bupivacaine—Dyspnoea—Bleomycin—skin cancer	0.00015	0.00157	CcSEcCtD
Bupivacaine—Headache—Imiquimod—skin cancer	0.000148	0.00155	CcSEcCtD
Bupivacaine—Anaemia—Fluorouracil—skin cancer	0.000148	0.00155	CcSEcCtD
Bupivacaine—Arthralgia—Temozolomide—skin cancer	0.000148	0.00155	CcSEcCtD
Bupivacaine—Infestation NOS—Docetaxel—skin cancer	0.000148	0.00155	CcSEcCtD
Bupivacaine—Infestation—Docetaxel—skin cancer	0.000148	0.00155	CcSEcCtD
Bupivacaine—Anxiety—Temozolomide—skin cancer	0.000147	0.00154	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000147	0.00154	CcSEcCtD
Bupivacaine—Decreased appetite—Bleomycin—skin cancer	0.000146	0.00153	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Docetaxel—skin cancer	0.000145	0.00152	CcSEcCtD
Bupivacaine—Pain—Bleomycin—skin cancer	0.000144	0.0015	CcSEcCtD
Bupivacaine—Confusional state—Temozolomide—skin cancer	0.000143	0.0015	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000143	0.00149	CcSEcCtD
Bupivacaine—Oedema—Temozolomide—skin cancer	0.000142	0.00148	CcSEcCtD
Bupivacaine—Anaphylactic shock—Temozolomide—skin cancer	0.000142	0.00148	CcSEcCtD
Bupivacaine—Infection—Temozolomide—skin cancer	0.000141	0.00147	CcSEcCtD
Bupivacaine—Nausea—Imiquimod—skin cancer	0.00014	0.00147	CcSEcCtD
Bupivacaine—Nervous system disorder—Temozolomide—skin cancer	0.000139	0.00145	CcSEcCtD
Bupivacaine—Convulsion—Fluorouracil—skin cancer	0.000139	0.00145	CcSEcCtD
Bupivacaine—Feeling abnormal—Bleomycin—skin cancer	0.000138	0.00145	CcSEcCtD
Bupivacaine—Skin disorder—Temozolomide—skin cancer	0.000138	0.00144	CcSEcCtD
Bupivacaine—Hyperhidrosis—Temozolomide—skin cancer	0.000137	0.00143	CcSEcCtD
Bupivacaine—Decreased appetite—Dactinomycin—skin cancer	0.000136	0.00143	CcSEcCtD
Bupivacaine—Pain—Dactinomycin—skin cancer	0.000134	0.0014	CcSEcCtD
Bupivacaine—Urticaria—Bleomycin—skin cancer	0.000133	0.0014	CcSEcCtD
Bupivacaine—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.000133	0.05	CbGpPWpGaD
Bupivacaine—Body temperature increased—Bleomycin—skin cancer	0.000133	0.00139	CcSEcCtD
Bupivacaine—Hypoaesthesia—Docetaxel—skin cancer	0.000132	0.00138	CcSEcCtD
Bupivacaine—Confusional state—Fluorouracil—skin cancer	0.000132	0.00138	CcSEcCtD
Bupivacaine—Oedema peripheral—Docetaxel—skin cancer	0.000131	0.00137	CcSEcCtD
Bupivacaine—Oedema—Fluorouracil—skin cancer	0.00013	0.00137	CcSEcCtD
Bupivacaine—Anaphylactic shock—Fluorouracil—skin cancer	0.00013	0.00137	CcSEcCtD
Bupivacaine—Infection—Fluorouracil—skin cancer	0.00013	0.00136	CcSEcCtD
Bupivacaine—Feeling abnormal—Dactinomycin—skin cancer	0.000129	0.00135	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000129	0.00135	CcSEcCtD
Bupivacaine—Insomnia—Temozolomide—skin cancer	0.000128	0.00134	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000128	0.00134	CcSEcCtD
Bupivacaine—Nervous system disorder—Fluorouracil—skin cancer	0.000128	0.00134	CcSEcCtD
Bupivacaine—Tachycardia—Fluorouracil—skin cancer	0.000127	0.00133	CcSEcCtD
Bupivacaine—Paraesthesia—Temozolomide—skin cancer	0.000127	0.00133	CcSEcCtD
Bupivacaine—Dyspnoea—Temozolomide—skin cancer	0.000126	0.00132	CcSEcCtD
Bupivacaine—Somnolence—Temozolomide—skin cancer	0.000126	0.00132	CcSEcCtD
Bupivacaine—Dyspepsia—Temozolomide—skin cancer	0.000125	0.00131	CcSEcCtD
Bupivacaine—Body temperature increased—Dactinomycin—skin cancer	0.000124	0.0013	CcSEcCtD
Bupivacaine—Abdominal pain—Dactinomycin—skin cancer	0.000124	0.0013	CcSEcCtD
Bupivacaine—Hypersensitivity—Bleomycin—skin cancer	0.000124	0.0013	CcSEcCtD
Bupivacaine—Decreased appetite—Temozolomide—skin cancer	0.000123	0.00129	CcSEcCtD
Bupivacaine—Flushing—Docetaxel—skin cancer	0.000123	0.00129	CcSEcCtD
Bupivacaine—Cardiac disorder—Docetaxel—skin cancer	0.000123	0.00129	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000122	0.00128	CcSEcCtD
Bupivacaine—Hypotension—Fluorouracil—skin cancer	0.000122	0.00128	CcSEcCtD
Bupivacaine—Constipation—Temozolomide—skin cancer	0.000121	0.00127	CcSEcCtD
Bupivacaine—Pain—Temozolomide—skin cancer	0.000121	0.00127	CcSEcCtD
Bupivacaine—Asthenia—Bleomycin—skin cancer	0.00012	0.00126	CcSEcCtD
Bupivacaine—Chills—Docetaxel—skin cancer	0.000119	0.00125	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000119	0.00125	CcSEcCtD
Bupivacaine—Pruritus—Bleomycin—skin cancer	0.000119	0.00124	CcSEcCtD
Bupivacaine—Arrhythmia—Docetaxel—skin cancer	0.000118	0.00124	CcSEcCtD
Bupivacaine—Insomnia—Fluorouracil—skin cancer	0.000118	0.00124	CcSEcCtD
Bupivacaine—Paraesthesia—Fluorouracil—skin cancer	0.000117	0.00123	CcSEcCtD
Bupivacaine—Feeling abnormal—Temozolomide—skin cancer	0.000117	0.00122	CcSEcCtD
Bupivacaine—Dyspnoea—Fluorouracil—skin cancer	0.000116	0.00122	CcSEcCtD
Bupivacaine—Mental disorder—Docetaxel—skin cancer	0.000116	0.00122	CcSEcCtD
Bupivacaine—Somnolence—Fluorouracil—skin cancer	0.000116	0.00122	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Temozolomide—skin cancer	0.000116	0.00121	CcSEcCtD
Bupivacaine—Malnutrition—Docetaxel—skin cancer	0.000115	0.00121	CcSEcCtD
Bupivacaine—Erythema—Docetaxel—skin cancer	0.000115	0.00121	CcSEcCtD
Bupivacaine—Hypersensitivity—Dactinomycin—skin cancer	0.000115	0.00121	CcSEcCtD
Bupivacaine—Dyspepsia—Fluorouracil—skin cancer	0.000115	0.0012	CcSEcCtD
Bupivacaine—Decreased appetite—Fluorouracil—skin cancer	0.000113	0.00119	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000113	0.00118	CcSEcCtD
Bupivacaine—Urticaria—Temozolomide—skin cancer	0.000112	0.00118	CcSEcCtD
Bupivacaine—Asthenia—Dactinomycin—skin cancer	0.000112	0.00118	CcSEcCtD
Bupivacaine—Abdominal pain—Temozolomide—skin cancer	0.000112	0.00117	CcSEcCtD
Bupivacaine—Body temperature increased—Temozolomide—skin cancer	0.000112	0.00117	CcSEcCtD
Bupivacaine—Back pain—Docetaxel—skin cancer	0.000112	0.00117	CcSEcCtD
Bupivacaine—Pain—Fluorouracil—skin cancer	0.000112	0.00117	CcSEcCtD
Bupivacaine—Muscle spasms—Docetaxel—skin cancer	0.000111	0.00116	CcSEcCtD
Bupivacaine—Feeling abnormal—Fluorouracil—skin cancer	0.000108	0.00113	CcSEcCtD
Bupivacaine—Diarrhoea—Dactinomycin—skin cancer	0.000107	0.00112	CcSEcCtD
Bupivacaine—Vomiting—Bleomycin—skin cancer	0.000107	0.00112	CcSEcCtD
Bupivacaine—Anaemia—Docetaxel—skin cancer	0.000107	0.00112	CcSEcCtD
Bupivacaine—Hypersensitivity—Temozolomide—skin cancer	0.000104	0.00109	CcSEcCtD
Bupivacaine—Urticaria—Fluorouracil—skin cancer	0.000104	0.00109	CcSEcCtD
Bupivacaine—Syncope—Docetaxel—skin cancer	0.000103	0.00108	CcSEcCtD
Bupivacaine—Body temperature increased—Fluorouracil—skin cancer	0.000103	0.00108	CcSEcCtD
Bupivacaine—Palpitations—Docetaxel—skin cancer	0.000102	0.00107	CcSEcCtD
Bupivacaine—Asthenia—Temozolomide—skin cancer	0.000102	0.00106	CcSEcCtD
Bupivacaine—Loss of consciousness—Docetaxel—skin cancer	0.000101	0.00106	CcSEcCtD
Bupivacaine—Cough—Docetaxel—skin cancer	0.000101	0.00105	CcSEcCtD
Bupivacaine—Pruritus—Temozolomide—skin cancer	0.0001	0.00105	CcSEcCtD
Bupivacaine—Convulsion—Docetaxel—skin cancer	0.0001	0.00105	CcSEcCtD
Bupivacaine—Nausea—Bleomycin—skin cancer	9.97e-05	0.00104	CcSEcCtD
Bupivacaine—Hypertension—Docetaxel—skin cancer	9.96e-05	0.00104	CcSEcCtD
Bupivacaine—Vomiting—Dactinomycin—skin cancer	9.95e-05	0.00104	CcSEcCtD
Bupivacaine—Arthralgia—Docetaxel—skin cancer	9.82e-05	0.00103	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	9.76e-05	0.00102	CcSEcCtD
Bupivacaine—Diarrhoea—Temozolomide—skin cancer	9.69e-05	0.00102	CcSEcCtD
Bupivacaine—Hypersensitivity—Fluorouracil—skin cancer	9.61e-05	0.00101	CcSEcCtD
Bupivacaine—Confusional state—Docetaxel—skin cancer	9.5e-05	0.000995	CcSEcCtD
Bupivacaine—Oedema—Docetaxel—skin cancer	9.42e-05	0.000987	CcSEcCtD
Bupivacaine—Anaphylactic shock—Docetaxel—skin cancer	9.42e-05	0.000987	CcSEcCtD
Bupivacaine—Dizziness—Temozolomide—skin cancer	9.36e-05	0.000981	CcSEcCtD
Bupivacaine—Infection—Docetaxel—skin cancer	9.36e-05	0.00098	CcSEcCtD
Bupivacaine—Nausea—Dactinomycin—skin cancer	9.3e-05	0.000974	CcSEcCtD
Bupivacaine—Shock—Docetaxel—skin cancer	9.26e-05	0.000971	CcSEcCtD
Bupivacaine—Nervous system disorder—Docetaxel—skin cancer	9.24e-05	0.000967	CcSEcCtD
Bupivacaine—Pruritus—Fluorouracil—skin cancer	9.23e-05	0.000967	CcSEcCtD
Bupivacaine—Tachycardia—Docetaxel—skin cancer	9.19e-05	0.000963	CcSEcCtD
Bupivacaine—Skin disorder—Docetaxel—skin cancer	9.15e-05	0.000958	CcSEcCtD
Bupivacaine—Vomiting—Temozolomide—skin cancer	9e-05	0.000943	CcSEcCtD
Bupivacaine—Diarrhoea—Fluorouracil—skin cancer	8.93e-05	0.000935	CcSEcCtD
Bupivacaine—Headache—Temozolomide—skin cancer	8.87e-05	0.000929	CcSEcCtD
Bupivacaine—Hypotension—Docetaxel—skin cancer	8.8e-05	0.000922	CcSEcCtD
Bupivacaine—Dizziness—Fluorouracil—skin cancer	8.63e-05	0.000904	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Docetaxel—skin cancer	8.58e-05	0.000899	CcSEcCtD
Bupivacaine—Insomnia—Docetaxel—skin cancer	8.52e-05	0.000892	CcSEcCtD
Bupivacaine—Paraesthesia—Docetaxel—skin cancer	8.46e-05	0.000886	CcSEcCtD
Bupivacaine—Nausea—Temozolomide—skin cancer	8.41e-05	0.000881	CcSEcCtD
Bupivacaine—Dyspnoea—Docetaxel—skin cancer	8.4e-05	0.00088	CcSEcCtD
Bupivacaine—Somnolence—Docetaxel—skin cancer	8.37e-05	0.000877	CcSEcCtD
Bupivacaine—Vomiting—Fluorouracil—skin cancer	8.3e-05	0.000869	CcSEcCtD
Bupivacaine—Dyspepsia—Docetaxel—skin cancer	8.29e-05	0.000868	CcSEcCtD
Bupivacaine—Decreased appetite—Docetaxel—skin cancer	8.19e-05	0.000858	CcSEcCtD
Bupivacaine—Headache—Fluorouracil—skin cancer	8.17e-05	0.000856	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Docetaxel—skin cancer	8.13e-05	0.000852	CcSEcCtD
Bupivacaine—Pain—Docetaxel—skin cancer	8.05e-05	0.000844	CcSEcCtD
Bupivacaine—Constipation—Docetaxel—skin cancer	8.05e-05	0.000844	CcSEcCtD
Bupivacaine—Feeling abnormal—Docetaxel—skin cancer	7.76e-05	0.000813	CcSEcCtD
Bupivacaine—Nausea—Fluorouracil—skin cancer	7.75e-05	0.000812	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Docetaxel—skin cancer	7.7e-05	0.000807	CcSEcCtD
Bupivacaine—Body temperature increased—Docetaxel—skin cancer	7.44e-05	0.00078	CcSEcCtD
Bupivacaine—Abdominal pain—Docetaxel—skin cancer	7.44e-05	0.00078	CcSEcCtD
Bupivacaine—Hypersensitivity—Docetaxel—skin cancer	6.94e-05	0.000727	CcSEcCtD
Bupivacaine—Asthenia—Docetaxel—skin cancer	6.76e-05	0.000708	CcSEcCtD
Bupivacaine—Pruritus—Docetaxel—skin cancer	6.66e-05	0.000698	CcSEcCtD
Bupivacaine—Diarrhoea—Docetaxel—skin cancer	6.44e-05	0.000675	CcSEcCtD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	6.43e-05	0.0242	CbGpPWpGaD
Bupivacaine—Dizziness—Docetaxel—skin cancer	6.23e-05	0.000652	CcSEcCtD
Bupivacaine—Vomiting—Docetaxel—skin cancer	5.99e-05	0.000627	CcSEcCtD
Bupivacaine—Headache—Docetaxel—skin cancer	5.9e-05	0.000618	CcSEcCtD
Bupivacaine—Nausea—Docetaxel—skin cancer	5.59e-05	0.000586	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—SCN10A—skin cancer	5.02e-05	0.0189	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	4.63e-05	0.0174	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—PTCH2—skin cancer	4.18e-05	0.0157	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	3.97e-05	0.0149	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—SCN10A—skin cancer	3.58e-05	0.0135	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	3.05e-05	0.0115	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—MC1R—skin cancer	3.02e-05	0.0114	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—RASA1—skin cancer	2.89e-05	0.0108	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—RASA1—skin cancer	2.78e-05	0.0105	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	2.61e-05	0.00982	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RHOU—skin cancer	2.6e-05	0.00976	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—SHH—skin cancer	2.15e-05	0.0081	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTCH2—skin cancer	2.15e-05	0.00807	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—RASA1—skin cancer	2.06e-05	0.00774	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—PTCH1—skin cancer	2.04e-05	0.00768	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—SMO—skin cancer	2.04e-05	0.00768	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—PTGER4—skin cancer	1.99e-05	0.00747	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—RASA1—skin cancer	1.99e-05	0.00746	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—MC1R—skin cancer	1.71e-05	0.00642	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—MC1R—skin cancer	1.55e-05	0.00583	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTCH2—skin cancer	1.27e-05	0.00477	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PTGER4—skin cancer	1.12e-05	0.00422	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SHH—skin cancer	1.11e-05	0.00416	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SMO—skin cancer	1.05e-05	0.00394	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTCH1—skin cancer	1.05e-05	0.00394	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	1.04e-05	0.00389	CbGpPWpGaD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	1.04e-05	0.00389	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTGER4—skin cancer	1.02e-05	0.00384	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CDK4—skin cancer	1.01e-05	0.0038	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CDK4—skin cancer	9.74e-06	0.00366	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GLI2—skin cancer	9.61e-06	0.00361	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MC1R—skin cancer	9.17e-06	0.00345	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GLI1—skin cancer	9.03e-06	0.0034	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	8.91e-06	0.00335	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	8.62e-06	0.00324	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SUFU—skin cancer	8.57e-06	0.00322	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	8.06e-06	0.00303	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—NRAS—skin cancer	7.87e-06	0.00296	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	7.75e-06	0.00291	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—NRAS—skin cancer	7.59e-06	0.00285	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	7.58e-06	0.00285	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	7.25e-06	0.00273	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—KRAS—skin cancer	6.77e-06	0.00255	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	6.71e-06	0.00252	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SHH—skin cancer	6.53e-06	0.00246	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—KRAS—skin cancer	6.53e-06	0.00245	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RASA1—skin cancer	6.49e-06	0.00244	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SMO—skin cancer	6.19e-06	0.00233	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTCH1—skin cancer	6.19e-06	0.00233	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	6.04e-06	0.00227	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTGER4—skin cancer	6.03e-06	0.00227	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	5.77e-06	0.00217	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—HRAS—skin cancer	5.76e-06	0.00216	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—NRAS—skin cancer	5.61e-06	0.00211	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—HRAS—skin cancer	5.55e-06	0.00209	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—IL6—skin cancer	5.51e-06	0.00207	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—NRAS—skin cancer	5.41e-06	0.00203	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FOXO4—skin cancer	5.32e-06	0.002	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—IL6—skin cancer	5.31e-06	0.002	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	4.91e-06	0.00184	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—KRAS—skin cancer	4.83e-06	0.00182	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—KRAS—skin cancer	4.66e-06	0.00175	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—HRAS—skin cancer	4.11e-06	0.00154	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—HRAS—skin cancer	3.96e-06	0.00149	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—IL6—skin cancer	3.93e-06	0.00148	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—IL6—skin cancer	3.79e-06	0.00142	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TERT—skin cancer	3.56e-06	0.00134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PLIN2—skin cancer	3.45e-06	0.0013	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PLIN2—skin cancer	3.18e-06	0.00119	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—NRAS—skin cancer	3e-06	0.00113	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—BRAF—skin cancer	2.82e-06	0.00106	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CSPG4—skin cancer	2.78e-06	0.00105	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLIN2—skin cancer	2.69e-06	0.00101	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—KRAS—skin cancer	2.58e-06	0.000969	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CSPG4—skin cancer	2.56e-06	0.000962	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—HRAS—skin cancer	2.19e-06	0.000824	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CSPG4—skin cancer	2.17e-06	0.000815	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—skin cancer	2.1e-06	0.000789	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLIN2—skin cancer	2.08e-06	0.00078	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO2—skin cancer	1.89e-06	0.000711	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NRAS—skin cancer	1.77e-06	0.000665	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO2—skin cancer	1.74e-06	0.000654	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CSPG4—skin cancer	1.67e-06	0.000629	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KRAS—skin cancer	1.52e-06	0.000573	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.48e-06	0.000556	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO2—skin cancer	1.47e-06	0.000554	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—skin cancer	1.35e-06	0.000509	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HRAS—skin cancer	1.29e-06	0.000487	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—skin cancer	1.24e-06	0.000466	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.15e-06	0.000433	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO2—skin cancer	1.14e-06	0.000428	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ERCC2—skin cancer	1.1e-06	0.000413	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ERCC2—skin cancer	1.01e-06	0.00038	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ERCC2—skin cancer	8.56e-07	0.000322	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ERCC2—skin cancer	6.61e-07	0.000248	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—skin cancer	6.59e-07	0.000248	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—skin cancer	6.06e-07	0.000228	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—skin cancer	5.13e-07	0.000193	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—skin cancer	3.96e-07	0.000149	CbGpPWpGaD
